Cleveland Clinic Rheumatology and Immunology Series


 

Cleveland Clinic 2020 ACR Update on GCA: Is Tocilizumab + Ultra-Short Glucocorticoid Administration Effective for Newly Diagnosed Disease? Does Mavrilimumab Reduce Risk of Flare and Increase Sustained Remission?

339 views
November 20, 2020
Comments 0
Login to view comments. Click here to Login